Steven L Chang
Overview
Explore the profile of Steven L Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
2845
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Braun D, Moranzoni G, Chea V, McGregor B, Blass E, Tu C, et al.
Nature
. 2025 Feb;
639(8054):474-482.
PMID: 39910301
Personalized cancer vaccines (PCVs) can generate circulating immune responses against predicted neoantigens. However, whether such responses can target cancer driver mutations, lead to immune recognition of a patient's tumour and...
2.
Subramanian A, Vernon K, Zhou Y, Marshall J, Alimova M, Arevalo C, et al.
Cell Rep
. 2024 May;
43(6):114253.
PMID: 38781074
Diabetic kidney disease (DKD), the most common cause of kidney failure, is a frequent complication of diabetes and obesity, and yet to date, treatments to halt its progression are lacking....
3.
McKay R, Xie W, Yang X, Acosta A, Rathkopf D, Laudone V, et al.
Cancer
. 2024 Jan;
130(9):1629-1641.
PMID: 38161319
Background: Patients with localized, unfavorable intermediate-risk and high-risk prostate cancer have an increased risk of relapse after radical prostatectomy (RP). The authors previously reported on part 1 of this phase...
4.
DAndrea V, Qian Z, Yim K, Egan J, Magnani C, Feldman A, et al.
Urol Oncol
. 2023 Nov;
41(12):489.e1-489.e6.
PMID: 37980224
Introduction: Retroperitoneal lymph node dissection (RPLND) is the standard of care for testicular cancer in various disease settings. Deep vein thrombosis (DVT) complications have been reported to occur in <1%...
5.
Filipas D, Beatrici E, Nolazco J, Qian Z, Marks P, Labban M, et al.
JNCI Cancer Spectr
. 2023 Oct;
7(6).
PMID: 37802923
Background: Management of small renal masses often involves a nonoperative approach, but there is a paucity of information about the use and associated predictors of such approaches. This study aimed...
6.
Hakimi K, Saidian A, Panian J, Barata P, Berg S, Chang S, et al.
Clin Genitourin Cancer
. 2023 Aug;
21(6):694-702.
PMID: 37558529
Background: To evaluate effect and outcomes of combination primary immunotherapy (IO) and nephrectomy for advanced renal cell carcinoma (RCC). Methods: We conducted a multicenter, retrospective analysis of patients with advanced/metastatic...
7.
Yim K, Hsu S, Nolazco J, Cagney D, Mak R, DAndrea V, et al.
Eur Urol Oncol
. 2023 Jul;
7(1):147-150.
PMID: 37487813
Stereotactic magnetic resonance (MR)-guided adaptive radiotherapy (SMART) for renal cell carcinoma may result in more precise treatment delivery through the capabilities for improved image quality, daily adaptive planning, and accounting...
8.
von Landenberg N, Mossanen M, Wang Y, Sammon J, Hanna N, Gild P, et al.
Urol Pract
. 2023 Jun;
5(6):438-443.
PMID: 37312324
Introduction: Given the ongoing controversies regarding its benefit, prostate specific antigen based prostate cancer screening should be offered with patient preferences in mind. Understanding subsets of men who may or...
9.
McClintock T, Mossanen M, Shah M, Wang Y, Chung B, Chang S
Urol Pract
. 2023 Jun;
5(5):349-350.
PMID: 37312323
No abstract available.
10.
Meyer C, Friedlander D, Wang Y, Hollis M, Lipsitz S, Eswara J, et al.
Urol Pract
. 2023 Jun;
5(5):377-382.
PMID: 37312317
Introduction: Monopolar transurethral resection is the conventional surgical standard of care for bladder outlet obstruction due to benign prostatic enlargement. Bipolar resection and GreenLight™ photovaporization have emerged as options with...